NCT01160783Active, not recruiting
Genetic Contributions to Autism Spectrum Disorders
Source: ClinicalTrials.gov · Last updated 18 Jun 2026
Brief summary (registry, in English)
This study is working towards gaining a better understanding of the genetic and environmental factors involved in autism spectrum disorders (ASD), which includes autism, pervasive developmental disorder (PDD), and Asperger's syndrome. The investigators hope that information gained from this study will lead to new ways of diagnosing and treating ASDs.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 240 (actual)
- First submitted
- 9 Jul 2010
- Start date
- Apr 2007
- Primary completion date
- Dec 2028
- Lead sponsor
- Boston Children's Hospital
- Diseases
- Autism
- NCT number
- NCT01160783
What you commit to
- Study type: Observational
- Participants enrolled: 240
- From Apr 2007 to the primary completion date, Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Do not have the diagnosis of an ASD
- Participation in the "Phenotypic and Genetic Risk Factors in ASD" study at Boston Children's Hospital.
Who the study is looking for
- Clinical diagnosis of an Autism Spectrum Disorder (autism, pervasive developmental disorder (PDD), or Asperger's syndrome)
- Age \> 18 months
Age in the registry: 18 months to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Boston Children's Hospital Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.